| Primary |
| Ill-defined Disorder |
31.5% |
| Product Used For Unknown Indication |
13.8% |
| Drug Use For Unknown Indication |
12.3% |
| In Vitro Fertilisation |
11.5% |
| Hypertension |
3.8% |
| Maternal Exposure Timing Unspecified |
3.8% |
| Premature Labour |
3.1% |
| Depression |
1.5% |
| Diabetes Mellitus |
1.5% |
| Hormone Replacement Therapy |
1.5% |
| Hot Flush |
1.5% |
| Hypercholesterolaemia |
1.5% |
| Iron Deficiency Anaemia |
1.5% |
| Luteal Phase Deficiency |
1.5% |
| Maternal Therapy To Enhance Foetal Lung Maturity |
1.5% |
| Menopausal Symptoms |
1.5% |
| Menopause |
1.5% |
| Menorrhagia |
1.5% |
| Menstrual Disorder |
1.5% |
| Premature Menopause |
1.5% |
|
| Pyrexia |
11.1% |
| Tremor |
11.1% |
| Tonsillitis |
7.4% |
| Uterine Hypertonus |
7.4% |
| Vision Blurred |
7.4% |
| Aortic Valve Disease |
3.7% |
| Breast Cancer |
3.7% |
| Drug Administration Error |
3.7% |
| Food Poisoning |
3.7% |
| Haemangioma |
3.7% |
| Hepatic Adenoma |
3.7% |
| Hypospadias |
3.7% |
| Inflammation |
3.7% |
| Meningioma |
3.7% |
| Myocardial Infarction |
3.7% |
| Ovarian Hyperstimulation Syndrome |
3.7% |
| Ovarian Torsion |
3.7% |
| Pain In Extremity |
3.7% |
| Pancreatitis Acute |
3.7% |
| Poor Quality Sleep |
3.7% |
|
| Secondary |
| In Vitro Fertilisation |
40.2% |
| Product Used For Unknown Indication |
14.5% |
| Foetal Exposure During Pregnancy |
9.6% |
| Drug Use For Unknown Indication |
8.0% |
| Endometriosis |
6.8% |
| Enterobiasis |
2.4% |
| Hypertension |
2.4% |
| Prophylaxis |
2.0% |
| Blood Follicle Stimulating Hormone Decreased |
1.6% |
| Blood Luteinising Hormone Decreased |
1.6% |
| Diabetes Mellitus |
1.6% |
| Hormone Replacement Therapy |
1.6% |
| Infertility |
1.6% |
| Hypothyroidism |
1.2% |
| Blood Corticotrophin Decreased |
0.8% |
| Blood Thyroid Stimulating Hormone Decreased |
0.8% |
| Bronchitis Chronic |
0.8% |
| Dyslipidaemia |
0.8% |
| Endocrine Disorder |
0.8% |
| Essential Hypertension |
0.8% |
|
| Breast Cancer |
24.5% |
| Premature Baby |
12.2% |
| Pyrexia |
10.2% |
| Premature Delivery |
6.1% |
| Meningioma |
4.1% |
| Neoplasm Recurrence |
4.1% |
| Pancreatitis Acute |
4.1% |
| Pleural Effusion |
4.1% |
| Rash Scarlatiniform |
4.1% |
| Uterine Hypertonus |
4.1% |
| Weight Increased |
4.1% |
| Aortic Valve Disease |
2.0% |
| Cholestasis Of Pregnancy |
2.0% |
| Colitis |
2.0% |
| Complication Of Pregnancy |
2.0% |
| Foetal Disorder |
2.0% |
| Food Poisoning |
2.0% |
| Haemangioma |
2.0% |
| Hepatic Adenoma |
2.0% |
| Liver Disorder |
2.0% |
|
| Concomitant |
| Product Used For Unknown Indication |
22.9% |
| Drug Use For Unknown Indication |
14.0% |
| Ovulation Induction |
7.0% |
| Hormone Replacement Therapy |
6.1% |
| Prophylaxis |
5.6% |
| Ankylosing Spondylitis |
4.7% |
| Hiv Infection |
4.7% |
| Pain |
4.7% |
| Hypercoagulation |
3.3% |
| Menopause |
3.3% |
| Pregnancy |
3.3% |
| Bipolar Disorder |
2.8% |
| Diabetes Mellitus |
2.8% |
| Depression |
2.3% |
| Foetal Exposure During Pregnancy |
2.3% |
| General Anaesthesia |
2.3% |
| Hypertension |
2.3% |
| Contraception |
1.9% |
| Haemorrhage |
1.9% |
| Hiatus Hernia |
1.9% |
|
| Hepatitis Acute |
8.6% |
| Ovarian Hyperstimulation Syndrome |
8.6% |
| Premature Separation Of Placenta |
8.6% |
| Exposure During Pregnancy |
6.9% |
| Bartholin's Abscess |
5.2% |
| Cataract |
5.2% |
| Cholecystitis |
5.2% |
| Melanoma Recurrent |
5.2% |
| Premature Baby |
5.2% |
| Premature Labour |
5.2% |
| Tetany |
5.2% |
| Abortion Spontaneous |
3.4% |
| Abortion Threatened |
3.4% |
| Colonoscopy |
3.4% |
| Drug Exposure During Pregnancy |
3.4% |
| Gamma-glutamyltransferase Increased |
3.4% |
| Gastrointestinal Pain |
3.4% |
| Macular Degeneration |
3.4% |
| Myalgia |
3.4% |
| Nasal Polypectomy |
3.4% |
|
